title: [Treatment of glioblastoma multiforme].
abstract: The authors evaluate therapeutic results in 31 patients with the diagnosis of multiform glioblastoma. The comprehensive therapeutic procedure used as a rule which involves surgery, radiotherapy and in some instances also chemotherapy still gives very unsatisfactory results. The mean survival period of patients after surgery was 26.7 weeks and the mortality of patients within one month was 22.6%. Even radical surgery does not produce more favourable therapeutic results. Contemporary trends of preclinical and clinical research are focused in particular on different immunotherapeutic methods.
authors.affiliation: Neurochirurgická klinika FN, Olomouc.
authors.forename: M
authors.initials: M
authors.lastname: Kala
authors.forename: V
authors.initials: V
authors.lastname: Srámek
authors.forename: M
authors.initials: M
authors.lastname: Houdek
authors.forename: M
authors.initials: M
authors.lastname: Vaverka
authors.forename: P
authors.initials: P
authors.lastname: Zmrzlík
mesh_terms: D000368:Aged; D001932:Brain Neoplasms / Q000628:therapy*; D005260:Female; D005909:Glioblastoma / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged
vernacular_title: Zkusenosti s lécbou multiformního glioblastomu.